Furthermore, reduced HNRNPC expression was associated with a poor DFS prognosis for GBM (P = 0.014) and a poor OS prognosis for KIRC (P = 0.019) and THYM (P = 0.011). This evidence concerns the gene HNRNPC and glioblastoma.